source
- FDA officials share guidance on de novo device classifications and upcoming MDUFA VI changes at MedTech ConferenceAt the MedTech Conference in Boston, FDA officials and industry experts discussed de novo classification requests. They offered practical tips for companies seeking de novo designation, stressing…
- STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting downRecent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.STAT · 13d ago↗ source